https://www.nxtpsychedelics.com/news/articles/psychedelics/first-patient-dosed-in-beckley-psytechs-international-phase-iib-study-of-bpl-003-a-novel-synthetic-intranasal-formulation-of-5-meo-dmt-for-treatment-resistant-depression-trd/
First Patient Dosed in Beckley Psytech’s International Phase IIb Study of BPL-003, a Novel Synthetic Intranasal Formulation of 5-MeO-DMT, for Treatment Resistant Depression (TRD)